Kantoff PW - Search Results

1

Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer.

McKay RR, Zukotynski KA, Werner L, Voznesensky O, Wu JS, Smith SE, Jiang Z, Melnick K, Yuan X, Kantoff PW, Montgomery B, Balk SP, Taplin ME. McKay RR, et al. Among authors: kantoff pw. Prostate Cancer Prostatic Dis. 2014 Dec;17(4):325-31. doi: 10.1038/pcan.2014.28. Epub 2014 Aug 5. Prostate Cancer Prostatic Dis. 2014. PMID: 25091040 Free PMC article. Clinical Trial.

2

Management of hormone refractory prostate cancer: current standards and future prospects.

Oh WK, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. J Urol. 1998 Oct;160(4):1220-9. J Urol. 1998. PMID: 9751323 Review.

3

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma.

Oh WK, Manola J, Richie JP, Loughlin KR, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. Cancer. 1999 Oct 1;86(7):1329-34. doi: 10.1002/(sici)1097-0142(19991001)86:7<1329::aid-cncr31>3.0.co;2-r. Cancer. 1999. PMID: 10506721 Clinical Trial.

4

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer: a phase II study.

Smith MR, Kaufman D, Oh W, Guerin K, Seiden M, Makatsoris T, Manola J, Kantoff PW. Smith MR, et al. Among authors: kantoff pw. Cancer. 2000 Oct 15;89(8):1824-8. doi: 10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r. Cancer. 2000. PMID: 11042579 Clinical Trial.

5

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. Signoretti S, et al. J Natl Cancer Inst. 2000 Dec 6;92(23):1918-25. doi: 10.1093/jnci/92.23.1918. J Natl Cancer Inst. 2000. PMID: 11106683

6

Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.

George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ, Kantoff PW; Cancer and Leukemia Group B 9480. George DJ, et al. Among authors: kantoff pw. Clin Cancer Res. 2001 Jul;7(7):1932-6. Clin Cancer Res. 2001. PMID: 11448906

7

Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma: report of four cases.

Oh WK, George DJ, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. Cancer. 2002 Feb 1;94(3):686-9. doi: 10.1002/cncr.10269. Cancer. 2002. PMID: 11857300 Free article.

8

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer.

D'Amico AV, Saegaert T, Chen MH, Renshaw AA, George D, Oh W, Kantoff PW. D'Amico AV, et al. Among authors: kantoff pw. Cancer. 2002 Jul 15;95(2):275-80. doi: 10.1002/cncr.10673. Cancer. 2002. PMID: 12124826 Free article.

9

Chemotherapy for prostate cancer.

Gilligan T, Kantoff PW. Gilligan T, et al. Among authors: kantoff pw. Urology. 2002 Sep;60(3 Suppl 1):94-100; discussion 100. doi: 10.1016/s0090-4295(02)01583-2. Urology. 2002. PMID: 12231060 Review.

10

The epidemic of prostate cancer and the medical literature: a causal association?

Giovannucci E, Kantoff P, Spiegelman D, Loughlin KR, Wishnow KI, Corless C, McDermott A, Willet WC, Talcott JA. Giovannucci E, et al. Prostate Cancer Prostatic Dis. 1998 Mar;1(3):148-153. doi: 10.1038/sj.pcan.4500227. Prostate Cancer Prostatic Dis. 1998. PMID: 12496908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters